期刊文献+

肿瘤相关抗原CA72-4对胃癌临床诊断价值的系统评价 被引量:1

Systematic evaluation of CA72-4 for the clinical dignosis of gastric cancer
下载PDF
导出
摘要 目的系统评价肿瘤相关抗原CA72-4对胃癌的诊断效能。方法检索2002年1月至2008年12月万方中文科技期刊数据库和维普中文科技期刊数据库中关于CA72-4对胃癌的临床诊断价值的中文文献,对纳入文献进行质量评价及异质性检验,用统计分析软件计算综合受试者工作特征(SROC)曲线方程。结果共检索到2002年1月至2008年12月公开发表的关于CA72-4在胃癌临床诊断中的应用文献59篇,根据纳入和排除标准,经筛选后的7篇文献与本实验室研究结果共计7组数据进行Meta分析,样本总量为1748份。合并后的敏感度、特异度及优势比值分别为55.4%、91.5%和65.69。SROC曲线下面积为0.8746。结论CA72-4对胃癌具有中等水平的诊断价值。 Objective To assess the effect of tumor marker CA72-4 in the diagnosis of gastric cancer. Methods Relevant articles published in English and Chinese from January 2002 to December 2008 were searched for the data bases in Weipu and Wanfang full text. After the elicited articles were evaluated, the pooled sensitivity, specificity and odds rate were calculated by summary receiver operating charaeteristic (SROC) curve. Results From 59 related literatures index in the data bases, 7 articles involved in 1 748 samples were selected out to enter this meta-analysis,with the pooled sensitivity,specificity and odds tale being 55.4% , 91.5% and 65. 69 respectively. The area under the SROC curve was 0. 874 6. Conclusion CA72-4 has a moderate value in the diagnosis of gastric cancer .
出处 《检验医学与临床》 CAS 2009年第16期1322-1323,1325,共3页 Laboratory Medicine and Clinic
关键词 抗原 肿瘤相关 碳水化合物 META分析 胃肿瘤 评价研究 antigens, tumor-associated, carbohydrate meta-analysis stomach neoplasms evaluation studies
  • 相关文献

参考文献11

二级参考文献41

共引文献207

同被引文献19

  • 1Colcher D ,Hand PH,Nuti M ,et al. A spectrum of monoclonal anti- bodies Reactive with human mammary tumor cells [J]. Proc Nail Aead Sci U S A, 1981,78(5) :3199-3203.
  • 2Ubukata H,Katano M, Motohashi G,et al. Evaluation of CA72-4 as a tumor marker in patients with gastric cancer [J]. Gan To Kagaku Ryoho, 2003,30 ( 11 ) : 1821 - 1824.
  • 3Byrne DJ, Browning MC, Cuschieri A. CA72--4: a new tumour marker for gastric cancer [J ]. Br J Surg, 1990,77 (9) : 1010-1013.
  • 4Uear E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA,CA19-9,CA 72--4,and AFP levels in gastric cancer [J]. Adv Ther,2008,25 (10) : 1075-1084.
  • 5Kim DH, Oh SJ, Oh CA, et al. The relationships between perioperative CEA ,CA 19-9 ,and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy [J]. J Surg Oncol, 2011,104(6) :585-591.
  • 6Schutter EM ,Sohn C, Kristen P, et al. Estimation of probability of malignancy using a logistic model combinging physical exam ination,ultrasound,semm CA125,and serum CA72--4 in post- menopausal women with a pelvic mass:an international muhieenter study [J]. Gyneeol Oncol, 1998,69 ( 1 ) : 56-63.
  • 7Kobayashi H. The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer [J]. Nihon Sanka Fujinka Gakkai Zasshi, 1989,41 (5) :585-589.
  • 8Donach M ,Yu Y,Artioli G,et al. Combined use of biomarkers for detection of ovarian cancer in high-risk women [J]. Tumor Biol,2010,31(3):209-215.
  • 9Guadagni F,Roselli M,Ferroni P,et al. Clinical evaluation of the new tumor marker TAG-72 [J]. Anticancer Res,1991,11 (4): 1389-1394.
  • 10Filella X,Molina R,Menqual PJ,et al. Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9 [J]. J Nucl Biol Med, 1991,35(3) : 158-161.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部